[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4055 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 4055
To amend title XVIII of the Social Security Act to provide coverage and
payment under such title for certain treatments for dialysis-related
amyloidosis, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 20, 2025
Mr. Babin introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide coverage and
payment under such title for certain treatments for dialysis-related
amyloidosis, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Dialysis-Related Amyloidosis
Treatment Act of 2025''.
SEC. 2. COVERAGE AND PAYMENT FOR TREATMENTS FOR DIALYSIS-RELATED
AMYLOIDOSIS UNDER THE MEDICARE PROGRAM.
(a) Coverage.--Section 1861(s)(2) of the Social Security Act (42
U.S.C. 1395x(s)(2)), is amended--
(1) in subparagraph (JJ), by inserting ``and'' at the end;
and
(2) by adding at the end the following new subparagraph:
``(KK) treatments for dialysis-related amyloidosis (as
defined in subsection (nnn));''.
(b) Treatments for Dialysis-Related Amyloidosis Defined.--
(1) In general.--Section 1861 of the Social Security Act
(42 U.S.C. 1395x), is amended by adding at the end the
following new subsection:
``(nnn) Treatments for Dialysis-Related Amyloidosis.--The term
`treatments for dialysis-related amyloidosis' means any item or service
that is furnished in a dialysis facility (freestanding or hospital-
based) that is approved by the Food and Drug Administration for the
treatment of dialysis-related amyloidosis, and any supplies or services
that are provided adjunct to and are necessary for such treatment.''.
(2) Exclusion from renal dialysis services.--Section
1881(b)(14)(B) of the Social Security Act (42 U.S.C.
1395rr(b)(14)(B)) is amended by inserting before the period at
the end the following: ``or `treatments for dialysis-related
amyloidosis' (as defined in section 1861(nnn))''.
(c) Payment.--Section 1833(a)(1)(E) of the Social Security Act (42
U.S.C. 1395l(a)(1)(E)) is amended by inserting at the end the
following: ``except for treatments for dialysis-related amyloidosis,
which may not be included as a renal dialysis service for purposes of
payment under any prospective payment amount or comprehensive fee
established under section 1881, and for which payment shall be made
separately in the amount of 100 percent of the reasonable charges for
such items and services,''.
(d) Effective Date.--The amendments made by this section shall take
effect on the date of the enactment of this Act.
<all>